PARK RIDGE, Ill. (WLS) -- At the age of 4, Amelia was one of the first children to battle multisystem inflammatory syndrome, the rare COVID-related illness. Her parents thought it was appendicitis, ...

In a small trial, Mass General Brigham researchers have found that a drug designed to treat celiac disease supported a more rapid return to normal activities for patients following COVID. New research ...

Study reveals a mechanism behind multisystem inflammatory syndrome in children (MIS-C). Early in the COVID-19 pandemic, some children fought off COVID with few, if any, symptoms, only to go into organ ...

St. Jude Children's Research Hospital scientists have identified a link between a SARS-CoV-2 protein and the onset of multisystem inflammatory syndrome in children (MIS-C). MIS-C is a pediatric ...

MIS-C is a serious inflammatory shock that affects children. It can occur several weeks after a COVID infection and can be life-threatening. Until now, however, the precise cause of the condition was ...

SAN FRANCISCO (KGO) -- After four years of research and close to 200 blood samples from children across the country, San Francisco researchers have cracked the case. They now have an answer to a ...

In most cases of multisystem inflammatory syndrome in children, a rare condition that can occur after a COVID infection, kids present with gastrointestinal symptoms. In this small placebo-controlled ...

Faster resolution of GI symptoms, faster clearance of spike antigen, faster return to usual activities reported for children treated with larazotide. HealthDay News — Treatment of multisystem ...

RNA is expelled from cells via cell death or active release, and can then find its way into blood plasma. Medical researchers have now developed machine learning models that use these cell-free ...